Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Piramal Enterprises Limited
  6. Summary
    500302   INE140A01024

PIRAMAL ENTERPRISES LIMITED

(500302)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
2569.95 2580.65 2527 2365.7 2358.25 Last
16846 8121 16912 32337 25383 Volume
-0.07% +0.42% -2.08% -6.38% -0.31% Change
Estimated financial data (e)
Sales 2022 144 B 1 920 M 1 920 M
Net income 2022 24 818 M 332 M 332 M
Net Debt 2022 479 B 6 402 M 6 402 M
P/E ratio 2022 22,4x
Yield 2022 1,35%
Sales 2023 171 B 2 293 M 2 293 M
Net income 2023 32 783 M 439 M 439 M
Net Debt 2023 469 B 6 275 M 6 275 M
P/E ratio 2023 17,5x
Yield 2023 1,66%
Capitalization 563 B 7 529 M 7 528 M
EV / Sales 2022 7,25x
EV / Sales 2023 6,02x
Nbr of Employees 6 638
Free-Float -
More Financials
Company
Piramal Enterprises Limited (PEL) is engaged in diversified business, such as financial services and pharmaceuticals. PELÔÇÖs financial services offer a range of financial products and solutions, with wholesale and retail financing. The wholesale lending business provides financing to real estate developers, as well as corporate clients in non-real estate sectors. Within retail lending, PEL offers housing loans to... 
Sector
Consumer Lending
Calendar
02/09Earnings Release
More about the company
Ratings of Piramal Enterprises Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about PIRAMAL ENTERPRISES LIMITED
01/10PIRAMAL ENTERPRISES : Pharma Ltd. To Invest Minority Stake in Yapan Bio, India-Based CDMO ..
PU
2021Piramal Enterprises Appoints Rupen Jhaveri as Group President
CI
2021PIRAMAL ENTERPRISES : Organisational Announcement – Appointment of Rupen Jhaveri, Gr..
PU
2021Piramal Enterprises Arm Acquires Minority Stake in Yapan Bio for $13 Million
MT
2021PIRAMAL ENTERPRISES : Organisational Announcement – Resignation of Rajesh Laddha, ED..
PU
2021Shriram Capital Limited agreed to acquire Shrilekha Business Consultancy Private Limite..
CI
2021Shriram Transport Finance Company Limited agreed to acquire Shriram City Union Finance ..
CI
2021India central bank sidesteps proposal on corporate ownership of banks
RE
2021Banks, auto stocks drag Indian shares as inflation fears weigh
RE
2021Piramal Enterprises Limited Reports Earnings Results for the Second Quarter and Six Mon..
CI
2021Piramal Enterprises Limited Announces Consolidated Results for Q2 FY2022
PU
2021PIRAMAL ENTERPRISES : Announces Demerger and Simplification of Corporate Structure, To Cre..
AQ
2021PIRAMAL ENTERPRISES : to Demerge Pharma, Financial Services Business in Restructuring
MT
2021Piramal Group to Demerge Financial, Pharma Biz into Separate Listed Entities
CI
2021OIL AND NATURAL GAS : Indian shares end higher as auto stocks drive gains
RE
More news
News in other languages on PIRAMAL ENTERPRISES LIMITED
2021Piramal Enterprises nomme Rupen Jhaveri au poste de président du groupe
2021La branche de Piramal Enterprises acquiert une participation minoritaire dans Yapan Bio..
2021Piramal Enterprises Limited recommande le versement d'un dividende pour l'exercice clos..
2021Les indices indiens clôturent à plat alors que les transactions volatiles se poursuiven..
2021Piramal Enterprises Limited recommande le versement d'un dividende pour l'exercice clos..
More news
Chart PIRAMAL ENTERPRISES LIMITED
Duration : Period :
Piramal Enterprises Limited Technical Analysis Chart | 500302 | INE140A01024 | MarketScreener
Technical analysis trends PIRAMAL ENTERPRISES LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 2 358,25 INR
Average target price 3 120,43 INR
Spread / Average Target 32,3%
EPS Revisions
Managers and Directors
Peter D. DeYoung Chief Executive Officer
Bector Vikram Co-President & Chief Human Resources Officer
Vivek Valsaraj Co-President & Chief Financial Officer
Rupen Jhaveri President
Rajesh Ratanlal Laddha Group Chief Financial Officer & Executive Director
Sector and Competitors